6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
20m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
53m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
53m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
53m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
53m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) — investor relations, events, news, and company updates on 6ix.

Latest News

LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference

Lixte Biotech Holdings (LIXT) Advances Precision Oncology Strategy With LB-100, Expands Clinical and Strategic Partnerships

LIXTE Biotechnology Holdings (LIXT) Files 2025 Form 10-K, Highlights Transformational Year

LIXTE Biotechnology (LIXT) Has the World's Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

Financials

Revenue

$0

Market Cap

$33.69 M

EPS

-1.26

Community Chat

Ask AI